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Abstract 
Objectives: Guidelines recommend that patients suffering an ischaemic transient ischaemic 
attack (TIA) or stroke due to carotid artery stenosis should undergo carotid endarterectomy 
(CEA) within 14 days.  
Design: We examined the degree to which UK vascular units met this standard and whether 
rapid interventions were associated with procedural risks. 
Methods: The study analysed patients undergoing CEA between January 2009 and 
December 2014 from 100 UK NHS hospitals.  Data were collected on patient characteristics, 
intervals of time from symptoms to surgery, and 30-day postoperative outcomes.  The 
relationship between outcomes and time from symptom to surgery was evaluated using 
multilevel multivariable logistic regression. 
Results: In 23,235 patients, the median time from TIA/stroke to CEA decreased over time, 
from 22 days (IQR 10-56) in 2009 to 12 days (IQR 7-26) in 2014.  The proportion of patients 
treated within 14-days increased from 37% to 58%.  This improvement was produced by 
shorter times across the care pathway: symptoms to referral, from medical review to being 
seen by a vascular surgeon, and then to surgery.  The spread of the median time from 
symptom to surgery among NHS hospitals shrunk between 2009 and 2013 but then grew 
slightly. Low-, medium- and high-volume NHS hospitals all improved their performance 
similarly.  Performing CEA within 48 hours of symptom onset was associated with a small 
increase in the 30-day stroke and death rate: 3.1% (0-2 days) compared with 2.0% (3-7 days); 
adjusted odds ratio 1.64 (95% CI 1.04-2.59) but not with longer delays. 
Conclusions: The delay from symptom to CEA in symptomatic patients with ipsilateral 50-
99% carotid stenoses has reduced substantially, although 42% of patients underwent CEA 
after the recommended 14-days. The risk of stroke after CEA was low, but there may be a 
small increase in risk during the first 48 hours after symptoms.  
 
Keywords: carotid endarterectomy, stroke, symptomatic carotid artery stenosis, time to 
carotid endarterectomy, transient ischaemic attack 
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What does this study/review add to the existing literature and how will it influence 
future clinical practice? 
This paper demonstrates that, on a national level, the pathway from initial symptom to 
surgery for patients with symptomatic carotid stenosis, can be shortened to maximise the 
benefit of intervention, without increased perioperative risk in the period from 3-14 days. 
There may be a slight increase in perioperative risk of stroke and death in the first 48 hours. 
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Introduction 
Stroke is the second largest cause of death in the world causing 6,700,000 deaths each year1 
and is the fourth largest cause of death in the UK.2 There are more than 150,000 new strokes 
in the UK each year. Of these, one in eight are fatal within 30 days, while one in four are fatal 
within a year.2 Approximately 15% of ischaemic strokes are preceded by a transient 
ischaemic attack (TIA).2 Thromboembolism from an ipsilateral carotid artery stenosis is 
responsible for about 20% of all strokes.2,3 
Two landmark randomised trials; the North American Symptomatic Carotid Endarterectomy 
Trial (NASCET)4 and the European Carotid Surgery Trial (ECST),5 demonstrated the benefit 
of performing carotid endarterectomy (CEA) in symptomatic patients with a 50-99% internal 
carotid artery (ICA) stenosis. An individual patient meta-analysis of data from NASCET and 
ECST subsequently showed that maximum benefit was conferred if CEA was performed 
within 14 days of randomisation.6 Based on these findings, international guidelines 
increasingly recommend that CEA be performed within 2 weeks of an ischaemic 
cerebrovascular event (TIA or minor stroke) in symptomatic patients with ipsilateral high- 
(70-99%) or moderate-degree (50-69%) carotid artery stenoses.7-10  
In addition, there is growing evidence that the natural history risk of stroke in the first few 
days after TIA onset is much higher than previously thought in patients with 50-99% ICA 
stenoses. In a review of the published literature, eight natural history studies observed that the 
risk of stroke in the hyperacute period was 5-8% at 48 hours, 17% at 72 hours, 8-22% at 7 
days and 11-25% at 14 days11 again emphasizing the need for expedited CEA. 
Several studies have evaluated the delay between onset of symptoms to undergoing CEA.12-25 
Most 12-21,23-25 have demonstrated that only a minority of symptomatic patients undergo CEA 
within the recommended 2-week period from the index event. The reasons for excess delays 
to CEA are multifactorial including:  access to carotid imaging, long waiting times to 
theatre,16,17 delays in speed of referral to vascular surgeons13,14,16,25 and/or delays due to 
medical comorbidities (e.g. angina pectoris, cardiac workup, etc.).15,16,18,21 In addition, some 
surgeons have raised concerns about incurring a higher perioperative risk of stroke and/or 
death if CEA is performed soon after the neurological event26, especially in the first 48 
hours27. Conversely, studies which have reported delays of 12 weeks or more in performing 
CEA have observed recurrent stroke rates as high as 32%.28 Because of these very high rates 
of recurrent stroke, it has been suggested that vascular services with excessive delays in 
delivering CEA should probably not perform carotid revascularization procedures.29    
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In the UK, around 4000-5000 patients undergo CEA each year.  The National Carotid 
Interventions Audit was established in 2005 to assess the quality of care delivered to UK 
patients undergoing CEA, and has published annual reports on the patterns and outcomes of 
care since 200830. The aim of the study was to assess how the time period from onset of 
symptoms to undergoing CEA has changed between 2009 and 2014 in the United Kingdom.  
The results for data collected between December 2005 to September 2009 have been 
previously reported3,13.  
 
Materials and Methods 
The study is based on data extracted from the National Vascular Registry (NVR), a national 
clinical audit commissioned by the Healthcare Quality Improvement Partnership (HQIP) and 
which incorporated the previous national carotid interventions audit in January 2013.  The 
Registry covers five major vascular procedures and receives data from 97% of eligible 
National Health System (NHS) acute hospitals (hospital organisations) in England, Northern 
Ireland, Scotland and Wales.  The Registry supports the revalidation process for surgeons, 
and provides organisational level information for NHS hospitals to support the 
commissioning of vascular services. 
The study cohort was defined to be patients undergoing CEA for symptomatic carotid disease 
between 1 January 2009 and 31 December 2014.  Details on each patient, their treatment and 
postoperative outcomes are electronically entered by their supervising vascular surgeon or 
other hospital staff.  Patient characteristics included: age, sex, and indication for surgery, 
degree of ipsilateral and contralateral carotid disease, comorbidities and the pre-operative 
Rankin score.  Key dates were also collected to allow the time from occurrence of neurologic 
symptoms to undergoing CEA to be calculated, as well as for intervals along the care 
pathway. The ‘index’ symptom was defined as the symptom, which led the patient to seek 
medical advice. Defined time periods were: i) time from index symptom to first carotid 
imaging, ii) time from index symptom to date of referral to the medical team,  iii) time from 
referral to the date first seen by the vascular surgical team and (iv) time from date seen by the 
surgical team to undergoing CEA.  The NVR also collected data relating to the operation and 
complications occurring within 30 days of CEA including: death, bleeding, myocardial 
infarct, cranial nerve injury and stroke. 
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Temporal changes in the time between index symptom and undergoing CEA were calculated 
(annually) between January 2009 and December 2014.  Figures were calculated for the UK as 
a whole and for acute NHS hospitals individually.  We excluded data on a small number of 
NHS hospitals that did not perform at least one CEA for each year between 2009 and 2014, 
and we excluded patients missing one or more of the key dates.  We also examined whether 
changes in the time from index symptom to undergoing CEA was related to the volume of 
CEA activity within acute NHS hospitals. To take account of NHS hospital mergers, we used 
only those hospitals that existed on 31 December 2014. Using the average annual volume for 
each organisation, the NHS hospitals were divided into low, medium and high volume 
categories such that the three CEA volume groups contained approximately equal numbers of 
patients.  The range of annual activity covered by the three groups were: 34 or less (low 
volume), 35 to 54 procedures (medium volume) and 55 or more procedures (high volume).  
Finally, we examined the rates of 30-day stroke and death for various time periods between 
symptom onset and undergoing CEA, stratifying the interval into five groups (0-2 days, 3-7 
days, 8-14 days, 15-21 days and >21 days). Multilevel multivariable logistic regression was 
used to estimate the crude and adjusted effect of the time from symptom to surgery on the 
outcome variables.  The adjusted odds ratios derived from each regression model took into 
account patient age, presenting symptom, pre-operative ranking score, presence of diabetes or 
ischemic heart disease, and year of operation.  The NHS hospital of surgery was included as a 
random-intercept to account for any lack of independence in the data because of the 
clustering of patients within hospitals.  All statistical tests were two-sided and the level of 
statistical significance was set at 0.05. All statistical calculations were performed in STATA 
version 14.1 (StataCorp, College Station, TX, USA).   
 
Results 
A total of 33,194 CEA procedures were performed in 124 NHS hospitals between 1 January 
2009 and 31 December 2014.  Limiting analyses to include only those NHS hospitals that 
performed CEA over the entire five-year period removed 24 NHS hospitals (1,806 patients).  
In the remaining 31,388 patients, there were 4,268 patients who underwent CEA for 
asymptomatic disease (13.6%) and these were also excluded.  Finally, it was necessary to 
exclude a further 3,885 patients from analyses because there was incomplete data regarding 
date of the index symptom, referral date and treatment date for each patient.  
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The characteristics of the 23,235 remaining patients are summarised in Table 1.  The median 
age was 73 years and the majority were men. Comorbidities were common, with 21% having 
diabetes and 27% having a history of ischaemic heart disease. Previous ipsilateral carotid 
surgery was recorded for only 250 patients (1.1%).  The most common presenting symptom 
was a TIA (47.5%), followed by stroke (35.4%). The proportion of patients with 90-99% 
ipsilateral stenoses remained constant over the years at around 29%, but the proportion of 
patients with 50-69% ipsilateral stenoses increased from 17.4% in 2009 to 25.4% in 2014, 
with a corresponding fall in the prevalence of 70-90% stenoses. 
The median delay from index symptom to undergoing CEA reduced from 22 days (IQR 10-
56) in 2009 to 12 days (IQR 7-26) days by 2014 (Figure 1).  The proportion of patients who 
were treated within 14-days rose from 37% to 58%.  There was a sustained improvement 
from 2009 to 2013, though there was a slight increase in delays in 2014. This improvement 
was achieved by a systematic reduction in the time through each stage of the patient pathway, 
including symptom to first medical referral, from first medical referral to being seen by the 
vascular team, and from being seen by a vascular surgeon to undergoing CEA (Table 2). The 
longer times in 2014 appear to occur in the stage between the referral and medical review.  
The time from onset of symptoms to undergoing carotid imaging was also significantly 
reduced from a median of 5 days (IQR 2-15) in 2009 to 3 days (IQR 1-8) in 2014.   
Figure 2 shows the temporal changes in median delays from symptom onset to undergoing 
CEA for every UK NHS hospital performing CEA, stratified by year of the procedure. The 
graph shows a distinct reduction in the spread of median delays across the NHS hospitals 
over time, both in terms of the tail of longer median values and the central 50% of NHS 
hospitals, whose position is marked by the horizontal lines. In 2009, this central group of 
NHS hospitals had median delays that ranged from 15 to 40 days.  By 2014, the central group 
of NHS hospitals had median delays that ranged from 9 to 18 days.  There was also no 
evidence that the degree of improvement achieved by the NHS hospitals was related to the 
volume of CEA performed (Figure 3).  
The overall postoperative 30-day stroke and death rates after CEA were 1.85% (95% CI 1.67 
to 2.02) and 0.83% (95% CI 0.71 to 0.94).  The combined 30-day stroke and death rate was 
2.31% (95% CI 2.11 to 2.50).  The rates remained stable throughout the 6-year time period.  
Table 3 shows the relationship between the time from symptom to surgery and these three 
outcomes.  There is no evidence that the risk of death is associated with the length of delay, 
but there is evidence of an increased risk of stroke within 30-days for CEA performed in the 
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first 2 days after the index symptoms compared to operations performed between 3 and 7 
days after.  There is no evidence that longer intervals from index symptom to surgery are 
associated with the rate of these three outcomes. 
 
Discussion 
Following publication of ECST and NASCET, the 1995 American Heart Association (AHA) 
Guidelines advised that CEA was an appropriate intervention in recently symptomatic 
patients (defined as symptoms within the preceding 6 months) who had an ipsilateral 50-99% 
carotid stenosis, provided 30-day rates of death/stroke were <6%32. In 2008, NICE 
recommended that CEA should be performed within 14 days of symptom onset10, followed in 
2009 by the European Society of Vascular Surgery33. The reason for this major change in 
practice was that a meta-analysis of the pooled randomised trial data by the Carotid 
Endarterectomy Trialists Collaboration (CETC) had revealed that CEA conferred maximum 
benefit if performed within 14 days6.  
Based on the CETC meta-analysis, CEA conferred a 30% absolute risk reduction in stroke at 
five years when CEA was performed within 2 weeks in patients with a 70-99% symptomatic 
carotid stenosis.6 This benefit almost halved (ARR 17%) when CEA was performed between 
2-4 weeks and was reduced to nearly a third (ARR 11%) when CEA was delayed by more 
than four weeks.6 In addition, a review of 8 natural history studies has now shown that the 
early risk of stroke may be even higher than previously thought, with some studies reporting 
recurrent stroke rates of 5-8% at 48 hours, 17% at 72 hours, 8-22% at 7 days and 11-25% at 
14 days11.  
However, there have been concerns that performing CEA in the early time period after onset 
of symptoms may be associated with a significant increase in the procedural risk, which 
might then offset any benefit accruing to the patient26. These concerns appeared to be 
corroborated by one of the first national audits of practice. In the 2012 Swedish Vascular 
Audit (SwedVasc), only 6% of patients underwent CEA within 48 hours of symptom, but 
they incurred a 11.5% risk of death/stroke at 30-days27. Overall 63% underwent CEA within 
14 days of symptom onset. After 48 hours had elapsed, procedural risks after CEA ranged 
between 3-5%27. 
The current study, therefore, is only the second national audit to report on outcomes, 
stratified for delays to CEA and a number of key findings are worthy of comment. First; the 
time from onset of the index symptom to undergoing CEA has continued to decrease (year on 
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year) from 2009 to 2014. CEA was performed within 2 weeks of index symptom onset in 
only 37% in 2009, but had increased to 58% in 2014.  
Second, while there was a small but significant increase in the procedural risk when CEA was 
performed within 48 hours of the index symptom ((OR 1.63 (95%CI 1.05-2.54), a 4.1% peri-
operative risk is perfectly acceptable. Interestingly, a multi-regression analysis found no other 
clinical factors to be associated with an increase in the risk of perioperative stroke.  
Third, more than 40% of all symptomatic patients undergoing CEA in the UK in 2014 did not 
undergo their operation within 14 days. This is disappointing and requires further analysis.  
Somewhat disappointingly, the main three reasons neither changed in ranking, nor in their 
magnitude over the three-year time period30,34. The commonest reason was a delay in referral 
to the vascular surgeon. The second commonest was a delay in the patient seeking medical 
advice, while the third commonest were delays in accessing carotid imaging. In short, in 
addition to improving patient awareness about seeking urgent medical advice after symptom 
onset, Commissioners, Administrators and Clinicians in both primary and secondary care 
must work together to reconfigure referral, imaging and treatment pathways to ensure that 
patients can access CEA more rapidly. Evidence suggests that this can lead to significant 
reductions in the time from symptom onset to undergoing CEA22. 
Fourth, this audit has shown that the time from symptom onset to undergoing CEA does not 
seem to be affected by the volume of CEAs performed in the hospital.  
Previous reports have suggested that there may be an under provision of CEA in the UK.3,13 
These reports have determined that at least 10,000 patients who suffer a TIA or a minor 
stroke in the UK each year could potentially benefit from CEA. Despite this, the number of 
CEAs performed for symptomatic carotid stenosis represents half this number. The data from 
the current NVR report, therefore, supports the conclusions reached in previous reports3,13 If 
all 10,000 patients were to undergo CEA within 2 weeks of symptom onset, about 1,100 
ipsilateral ischaemic strokes would be prevented at 5 years.6  
This study does have potentially important limitations. Firstly, it only includes symptomatic 
patients who eventually underwent CEA. Symptomatic patients deemed to be at ‘high 
surgical risk’ and who were not offered surgery were not included. Secondly, a small 
percentage of patients undergoing CEA during this time period may not have been registered 
in the UK National CEA Clinical Audit.  Thirdly, a significant minority of patients did not 
have complete data relating to all the time points in the patient pathway entered onto the 
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NVR. Finally, the reasons for not performing CEA within 14 days of symptom onset were 
provided by vascular surgeons and (for the most part) surgeons were also responsible for 
reporting death/stroke rates at 30-days.  
In conclusion, the NVR has reported sustained national improvements in the delivery of CEA 
to 23,235 patients with recently symptomatic carotid stenosis, registered prospectively in the 
UK National CEA Clinical Audit from January 1, 2009 until December 31, 2014. The 
reduction in time from symptom to surgery has been achieved through a national quality 
improvement programme. Operating in the first 48 hours after symptom onset was associated 
with a small but significant increase in procedural risk, but this was still within accepted risk 
thresholds. Although the time to CEA has improved considerably in the last 5 years, more 
than half of all symptomatic patients still did not undergo CEA within 2 weeks of symptom 
onset. The commonest reasons for these delays have been identified and should be addressed 
in individual hospitals where delays consistently extend beyond 14 days.  
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Table 1: Characteristics of patients undergoing CEA for symptomatic disease between January 2009 and 
December 2014 in UK NHS trusts 
  n=23,235  
Age at surgery (years), Median (IQR)   73 (66 to 79) 
    
Male, n (%)  15,510 (66.8) 
    
Co-morbid conditions, n (%)    
   Diabetes  4,830 (20.8) 
   Ischaemic heart disease   6,334 (27.3) 
    
Pre-op drugs prior to surgery, n (%)    
   Antiplatelet/antithrombotic treatment  22,136 (95.3) 
   Statin therapy  20,320 (87.5) 
    
Index event among symptomatic patients, n (%)   
   TIA  11,029 (47.5) 
   Amaurosis fugax  3,553 (15.3) 
   Stroke  8,229 (35.4) 
   Other  424   (1.8) 
    
Rankin score prior to surgery, n (%) 0 9,299 (40.1) 
(missing = 31) 1 7,135 (30.7) 
 2 4,627 (19.9) 
 3-5 2,143   (9.2) 
    
Grade of ipsilateral carotid stenosis, n (%) <50% 244   (1.1) 
(missing =176) 50-69% 5,532 (24.0) 
 70-89% 10,531 (45.7) 
 90-99% 6,629 (28.7) 
 Occluded 123   (0.5) 
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Table 2: Temporal changes in the time from index symptom to carotid surgery between 
2009 and 2014, stratified by: index symptom to first medical review, medical review to 
first seen by vascular surgeon, surgeon to undergoing CEA 
 
Year of 
surgery 
Number 
of CEA 
Symptom to medical review Medical review to vasc. surgeon Vascular surgeon to CEA 
 Median IQR P5 - P95 Median IQR P5 - P95 Median IQR P5 - P95 
2009 2811 7 (3-20) (0-73) 1 (0-7) (0-31) 8 (3-20) (1-74) 
2010 3483 5 (2-16) (0-64) 1 (0-6) (0-26) 6 (3-15) (1-61) 
2011 4119 4 (2-12) (0-58) 1 (0-5) (0-22) 5 (2-11) (1-50) 
2012 4286 4 (2-10) (0-50) 1 (0-4) (0-18) 5 (2-10) (1-48) 
2013 4242 4 (1- 9) (0-41) 1 (0-3) (0-16) 5 (2- 9) (1-39) 
2014 4294 4 (2-11) (0-58) 1 (0-3) (0-15) 5 (2- 9) (1-36) 
 
 
KEY: IQR = interquartile range. P5 and P95 = 5th and 95th percentile 
* For the three stages of the care pathway (symptom to medical review, review to vascular 
surgeon assessment, assessment to CEA), data were missing for 23, 77 and 63 patients, 
respectively. 
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Table 3: Postoperative 30-day stroke and death rates after CEA stratified for delay 
from onset of index symptom to undergoing CEA 
 
Delay Operations Crude 
rate (%) 
Crude 
odds ratio 
Adjusted  
odds ratio 
 
95% CI 
Stroke within 30 days      
 0 to 2 780 3.1 1.58 1.64 1.04 - 2.59 
 3 to 7 5,126 2.0 1 1  
 7 to 14 6,292 1.7 0.84 0.85 0.64 - 1.12 
 15 to 21 2,765 2.1 1.05 1.09 0.78 - 1.52 
 22 plus 8,272 1.7 0.88 0.94 0.72 - 1.23 
       
Death within 30 days      
 0 to 2 780 1.0 1.12 1.21 0.57 - 2.58 
 3 to 7 5126 0.9 1 1  
 7 to 14 6292 0.7 0.81 0.81 0.54 - 1.21 
 15 to 21 2765 1.1 1.19 1.24 0.78 - 1.97 
 22 plus 8272 0.7 0.80 0.96 0.65 - 1.43 
       
Stroke or Death within 30 days     
 0 to 2 780 3.7 1.52 1.59 1.05 - 2.41 
 3 to 7 5126 2.5 1 1  
 7 to 14 6292 2.1 0.84 0.84 0.65 - 1.08 
 15 to 21 2765 2.6 1.06 1.10 0.82 - 1.49 
 22 plus 8272 2.2 0.89 0.98 0.77 - 1.25 
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Figure 1: Distribution time from index symptom to carotid surgery by year of procedure.  
Boxes shows interquartile limits with median line.  Whisker limits set to 5th and 95th 
percentiles.  
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Figure 2: Dot plot of the median time from index symptom to carotid surgery for each NHS 
trusts by year of procedures*. Red lines show the 25th and 75th percentile within the 
distribution of NHS trust medians. 
 
 
 
* Two highest values (179 and 207) in 2009 were winzorised to 150 days to reduce their effect on the scale of 
the vertical axis. 
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Figure 3: Changes in the proportion of patients whose time from index symptom to surgery 
exceeded 14 days among NHS trusts that were categorised by annual surgical volume as low 
(<34 pa), medium (35-54 pa) or high volume (>55 pa).  
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